伊诺维奥制药(INO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

INO 伊诺维奥制药

未开盘 06-04 16:00:00 EDT

1.16

+0.02

+1.75%

盘后1.16

+0.00+0.28%

19:39 EDT

最高1.20	最低1.15	成交量130.79万
今开1.15	昨收1.14	日振幅3.95%
总市值9,544万	流通市值9,425万	总股本8,227万
成交额154.12万	换手率1.61%	流通股本8,125万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"INO","market":"US","secType":"STK","nameCN":"伊诺维奥制药","latestPrice":1.16,"timestamp":1780603200000,"preClose":1.14,"halted":0,"volume":1307856,"hourTrading":{"tag":"盘后","latestPrice":1.1633,"preClose":1.16,"latestTime":"19:39 EDT","volume":7584,"amount":8898.7938,"timestamp":1780616346961,"change":0.0033,"changeRate":0.002845,"amplitude":0.017241},"delay":0,"changeRate":0.017543859649122823,"floatShares":81249400,"shares":82273237,"eps":-1.558179,"marketStatus":"未开盘","change":0.02,"latestTime":"06-04 16:00:00 EDT","open":1.15,"high":1.195,"low":1.15,"amount":1541168.8785504,"amplitude":0.039474,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.558179,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1780646400000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":913093200000,"exchange":"NASDAQ","adjPreClose":1.14,"preHourTrading":{"tag":"盘前","latestPrice":1.17,"preClose":1.14,"latestTime":"09:20 EDT","volume":13523,"amount":15803.507901600002,"timestamp":1780579209430,"change":0.03,"changeRate":0.026316,"amplitude":0.052632},"postHourTrading":{"tag":"盘后","latestPrice":1.1633,"preClose":1.16,"latestTime":"19:39 EDT","volume":7584,"amount":8898.7938,"timestamp":1780616346961,"change":0.0033,"changeRate":0.002845,"amplitude":0.017241},"volumeRatio":0.861548,"impliedVol":1.4714,"impliedVolPercentile":0.6932},"requestUrl":"/m/hq/s/INO","defaultTab":"news","newsList":[{"id":"1177085246","title":"伊诺维奥制药VGX-3100三期试验达到主要终点，安全性表现良好","url":"https://stock-news.laohu8.com/highlight/detail?id=1177085246","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177085246?lang=zh_cn&edition=full","pubTime":"2026-05-22 04:23","pubTimestamp":1779394995,"startTime":"0","endTime":"0","summary":"伊诺维奥制药公司宣布，其候选药物VGX-3100的三期临床试验已达到主要疗效终点，同时展现出良好的安全性特征。该试验的成功标志着公司在该治疗领域取得了重要进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","INO","BK4139","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174097623","title":"Apollobio公布VGX-3100治疗宫颈发育不良三期试验积极顶线结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1174097623","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174097623?lang=zh_cn&edition=full","pubTime":"2026-05-22 04:06","pubTimestamp":1779393977,"startTime":"0","endTime":"0","summary":"中国合作伙伴Apollobio宣布，针对宫颈发育不良患者的VGX-3100三期临床试验取得了积极的顶线结果。该试验由Apollobio与伊诺维奥制药合作开展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4583","BK4568","INO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185397635","title":"FDA正积极审查伊诺维奥制药Ino-3107生物制剂许可申请，加速审批通道下PDUFA日期定于2026年10月30日","url":"https://stock-news.laohu8.com/highlight/detail?id=1185397635","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185397635?lang=zh_cn&edition=full","pubTime":"2026-05-14 04:28","pubTimestamp":1778704112,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）正依据加速审批程序，积极审查伊诺维奥制药（Inovio Pharmaceuticals）旗下候选药物Ino-3107的生物制剂许可申请（BLA）。该申请的处方药使用者付费法案（PDUFA）目标日期已确定为2026年10月30日。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4568","INO","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110343871","title":"伊诺维奥制药公布公开募股定价：发行1250万股及认股权证，每股1.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1110343871","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110343871?lang=zh_cn&edition=full","pubTime":"2026-04-02 21:02","pubTimestamp":1775134935,"startTime":"0","endTime":"0","summary":"伊诺维奥制药公司（Inovio Pharmaceuticals）近日宣布，其公开发行方案已正式定价。该公司计划发行总计1250万股普通股，并附带购买同等数量普通股的认股权证，发行价格为每股1.40美元。\n此次募股活动旨在为公司运营及管线开发注入新资金。发行条款显示，每股普通股将与一份认股权证一同发行，认股权证的行权价格等相关细节有待进一步披露。\n市场正密切关注此次融资对伊诺维奥制药未来战略布局的影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4139","INO","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171165936","title":"伊诺维奥制药暂停并终止与奥本海默公司的ATM发售计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1171165936","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171165936?lang=zh_cn&edition=full","pubTime":"2026-04-02 18:17","pubTimestamp":1775125034,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会（SEC）的最新文件披露，生物技术公司伊诺维奥制药已正式暂停并终止了其与投资银行奥本海默公司此前达成的“按市价发行”（ATM）股权发售计划的相关招股说明书。\n此项决定意味着，伊诺维奥制药将暂时无法通过该ATM融资机制在公开市场灵活地发售新股以募集资金。ATM发行方式通常允许上市公司在需要时，根据市场情况伺机发行股票，是一种灵活高效的融资工具。此次计划的终止，可能反映出公司当前融资策略的调整，或是基于对市场环境的考量。\n市场参与者将密切关注此举对公司未来资金状况及研发管线推进可能产生的影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","BK4139","INO","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617543254","title":"伊诺维奥制药盘中异动 早盘快速上涨5.06%报1.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2617543254","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617543254?lang=zh_cn&edition=full","pubTime":"2026-03-04 23:16","pubTimestamp":1772637380,"startTime":"0","endTime":"0","summary":"北京时间2026年03月04日23时16分，伊诺维奥制药股票出现波动，股价急速上涨5.06%。截至发稿，该股报1.77美元/股，成交量11.6839万股，换手率0.17%，振幅2.89%。伊诺维奥制药股票所在的生物技术行业中，整体涨幅为0.27%。伊诺维奥制药公司简介：Inovio Pharmaceuticals Inc 是一家总部位于美国的生物技术公司。该公司专注于开发和商业化 DNA 药物，以帮助治疗和保护人们免受 HPV 相关疾病、癌症和传染病的侵害。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304231620a44bd14f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304231620a44bd14f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INO","BK4568","BK4139","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107150570","title":"伊诺维奥制药与康方生物达成临床合作 共同推进胶质母细胞瘤创新联合疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=1107150570","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107150570?lang=zh_cn&edition=full","pubTime":"2026-03-04 21:06","pubTimestamp":1772629577,"startTime":"0","endTime":"0","summary":"伊诺维奥制药与康方生物宣布，双方已就一项针对胶质母细胞瘤（GBM）的新型联合疗法达成临床合作协议。此次合作旨在加速该创新疗法的研发进程，为胶质母细胞瘤患者探索新的治疗选择。\n胶质母细胞瘤是一种侵袭性强、预后较差的脑部恶性肿瘤，目前临床治疗选择有限，存在巨大的未满足医疗需求。两家公司计划通过联合各自的优势研发平台与技术，推动该联合疗法的临床开发，以期改善患者的生存预后。\n此次合作将结合伊诺维奥制药在免疫疗法领域的专长与康方生物在肿瘤创新药物开发方面的经验。双方期待通过资源整合与协同效应，加速这一重要治疗方案的开发步伐，为全球胶质母细胞瘤患者带来新的希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2476274720.SGD","LU1794554557.SGD","BK4139","LU0540923850.HKD","LU2488822045.USD","BK4568","09926","LU0348784397.USD","IE00B5MMRT66.SGD","LU0348825331.USD","LU2778985437.USD","LU2399975544.HKD","LU0634319403.HKD","LU1720050803.USD","BK1574","LU0561508036.HKD","LU2476274308.USD","BK1161","IE00BPRC5H50.USD","LU0348827113.USD","LU0348767384.USD","LU0417516902.SGD","BK4583","IE00B543WZ88.USD","LU1961090484.USD","LU0417516738.SGD","LU0348766576.USD","INO","LU0348783233.USD","LU0348735423.USD","LU0417516571.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609566599","title":"伊诺维奥制药盘中异动 急速跳水5.39%报1.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609566599","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609566599?lang=zh_cn&edition=full","pubTime":"2026-02-06 01:56","pubTimestamp":1770314163,"startTime":"0","endTime":"0","summary":"北京时间2026年02月06日01时56分，伊诺维奥制药股票出现波动，股价急速下跌5.39%。截至发稿，该股报1.58美元/股，成交量57.9642万股，换手率0.84%，振幅8.17%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。伊诺维奥制药股票所在的生物技术行业中，整体跌幅为0.79%。伊诺维奥制药公司简介：Inovio Pharmaceuticals Inc 是一家总部位于美国的生物技术公司。该公司专注于开发和商业化 DNA 药物，以帮助治疗和保护人们免受 HPV 相关疾病、癌症和传染病的侵害。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206015603a481293b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206015603a481293b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4583","BK4568","BK4139","INO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607054587","title":"伊诺维奥制药盘中异动 股价大涨5.23%报1.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607054587","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607054587?lang=zh_cn&edition=full","pubTime":"2026-01-30 02:57","pubTimestamp":1769713026,"startTime":"0","endTime":"0","summary":"北京时间2026年01月30日02时57分，伊诺维奥制药股票出现波动，股价快速拉升5.23%。截至发稿，该股报1.61美元/股，成交量110.351万股，换手率1.61%，振幅7.19%。机构评级方面，在所有6家参与评级的机构中，67%的券商给予买入建议，33%的券商给予持有建议，无券商给予卖出建议。伊诺维奥制药股票所在的生物技术行业中，整体跌幅为0.42%。伊诺维奥制药公司简介：Inovio Pharmaceuticals Inc 是一家总部位于美国的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026013002570697a407f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026013002570697a407f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","INO","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601364819","title":"伊诺维奥制药盘中异动 急速下挫5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601364819","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601364819?lang=zh_cn&edition=full","pubTime":"2026-01-06 23:07","pubTimestamp":1767712055,"startTime":"0","endTime":"0","summary":"北京时间2026年01月06日23时07分，伊诺维奥制药股票出现波动，股价急速下挫5.03%。截至发稿，该股报1.51美元/股，成交量90.2831万股，换手率1.31%，振幅5.66%。机构评级方面，在所有6家参与评级的机构中，67%的券商给予买入建议，33%的券商给予持有建议，无券商给予卖出建议。伊诺维奥制药股票所在的生物技术行业中，整体涨幅为1.19%。伊诺维奥制药公司简介：Inovio Pharmaceuticals Inc 是一家总部位于美国的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106230736a6fae945&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106230736a6fae945&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INO","BK4583","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2595040739","title":"伊诺维奥制药盘中异动 早盘快速跳水20.10%报1.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2595040739","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595040739?lang=zh_cn&edition=full","pubTime":"2025-12-29 22:31","pubTimestamp":1767018704,"startTime":"0","endTime":"0","summary":"北京时间2025年12月29日22时31分，伊诺维奥制药股票出现异动，股价大幅下跌20.10%。截至发稿，该股报1.83美元/股，成交量57.1763万股，换手率0.83%，振幅5.24%。机构评级方面，在所有6家参与评级的机构中，67%的券商给予买入建议，33%的券商给予持有建议，无券商给予卖出建议。伊诺维奥制药股票所在的生物技术行业中，整体跌幅为0.26%。伊诺维奥制药公司简介：Inovio Pharmaceuticals Inc 是一家总部位于美国的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229223144a6dd7d85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229223144a6dd7d85&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","INO","BK4583","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125719412","title":"伊诺维奥制药公司：目前暂无计划通过传统途径为Ino-3107寻求批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1125719412","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125719412?lang=zh_cn&edition=full","pubTime":"2025-12-29 21:06","pubTimestamp":1767013615,"startTime":"0","endTime":"0","summary":"伊诺维奥制药公司（Inovio Pharmaceuticals）近日透露，其当前的发展策略中，并未包含通过传统审批途径为旗下药物Ino-3107寻求上市许可的计划。这一决定反映了公司在药物开发路径上的战略考量，或预示着其可能探索其他加速审批的替代方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4583","BK4139","INO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517985310","title":"伊诺维奥制药盘中异动 急速拉升5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517985310","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517985310?lang=zh_cn&edition=full","pubTime":"2025-03-05 04:20","pubTimestamp":1741119617,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日04时20分，伊诺维奥制药股票出现波动，股价急速拉升5.43%。截至发稿，该股报1.94美元/股，成交量49.8997万股，换手率1.38%，振幅7.07%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。伊诺维奥制药股票所在的生物技术行业中，整体涨幅为0.13%。伊诺维奥制药公司简介：Inovio Pharmaceuticals Inc是一家总部位于美国的生物技术公司，致力于开发基于DNA的活性免疫疗法和疫苗，以治疗和预防癌症和传染病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305042017abe85268&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305042017abe85268&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INO","BK4583","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516124657","title":"伊诺维奥制药盘中异动 大幅下跌5.30%报1.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516124657","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516124657?lang=zh_cn&edition=full","pubTime":"2025-03-04 03:18","pubTimestamp":1741029490,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日03时18分，伊诺维奥制药股票出现异动，股价快速下跌5.30%。截至发稿，该股报1.88美元/股，成交量40.3712万股，换手率1.12%，振幅5.81%。伊诺维奥制药股票所在的生物技术行业中，整体涨幅为0.37%。伊诺维奥制药公司简介：Inovio Pharmaceuticals Inc是一家总部位于美国的生物技术公司，致力于开发基于DNA的活性免疫疗法和疫苗，以治疗和预防癌症和传染病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304031811989a4ef1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304031811989a4ef1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","BK4583","INO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514857133","title":"伊诺维奥制药盘中异动 早盘急速上涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514857133","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514857133?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:47","pubTimestamp":1740667654,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时47分，伊诺维奥制药股票出现波动，股价急速拉升5.05%。截至发稿，该股报2.08美元/股，成交量5.7309万股，换手率0.16%，振幅4.80%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。伊诺维奥制药股票所在的生物技术行业中，整体涨幅为0.80%。伊诺维奥制药公司简介：Inovio Pharmaceuticals Inc是一家总部位于美国的生物技术公司，致力于开发基于DNA的活性免疫疗法和疫苗，以治疗和预防癌症和传染病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227224734a2567e46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227224734a2567e46&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4583","INO","BK4139","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514048860","title":"伊诺维奥制药盘中异动 股价大跌5.45%报1.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514048860","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514048860?lang=zh_cn&edition=full","pubTime":"2025-02-26 02:28","pubTimestamp":1740508126,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日02时28分，伊诺维奥制药股票出现波动，股价快速下挫5.45%。截至发稿，该股报1.91美元/股，成交量36.2775万股，换手率1.00%，振幅6.44%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。伊诺维奥制药股票所在的生物技术行业中，整体涨幅为0.09%。伊诺维奥制药公司简介：Inovio Pharmaceuticals Inc是一家总部位于美国的生物技术公司，致力于开发基于DNA的活性免疫疗法和疫苗，以治疗和预防癌症和传染病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226022846a253bdec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226022846a253bdec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","BK4583","INO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513720448","title":"伊诺维奥制药盘中异动 早盘股价大跌5.36%报2.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513720448","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513720448?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:57","pubTimestamp":1740409045,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时57分，伊诺维奥制药股票出现波动，股价急速跳水5.36%。截至发稿，该股报2.12美元/股，成交量17.1021万股，换手率0.47%，振幅5.80%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。伊诺维奥制药股票所在的生物技术行业中，整体涨幅为0.22%。伊诺维奥制药公司简介：Inovio Pharmaceuticals Inc是一家总部位于美国的生物技术公司，致力于开发基于DNA的活性免疫疗法和疫苗，以治疗和预防癌症和传染病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225725962e9f59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225725962e9f59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","INO","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512743601","title":"伊诺维奥制药盘中异动 下午盘急速上涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512743601","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512743601?lang=zh_cn&edition=full","pubTime":"2025-02-20 04:02","pubTimestamp":1739995329,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日04时02分，伊诺维奥制药股票出现波动，股价大幅上涨5.02%。截至发稿，该股报2.30美元/股，成交量54.5782万股，换手率1.51%，振幅7.76%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。伊诺维奥制药股票所在的生物技术行业中，整体涨幅为0.55%。伊诺维奥制药公司简介：Inovio Pharmaceuticals Inc是一家总部位于美国的生物技术公司，致力于开发基于DNA的活性免疫疗法和疫苗，以治疗和预防癌症和传染病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220040209abd53973&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220040209abd53973&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INO","BK4568","BK4139","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512164420","title":"伊诺维奥制药盘中异动 股价大涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512164420","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512164420?lang=zh_cn&edition=full","pubTime":"2025-02-18 23:52","pubTimestamp":1739893934,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日23时52分，伊诺维奥制药股票出现波动，股价大幅拉升5.12%。截至发稿，该股报2.26美元/股，成交量38.7058万股，换手率1.07%，振幅4.42%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。伊诺维奥制药股票所在的生物技术行业中，整体涨幅为0.87%。伊诺维奥制药公司简介：Inovio Pharmaceuticals Inc是一家总部位于美国的生物技术公司，致力于开发基于DNA的活性免疫疗法和疫苗，以治疗和预防癌症和传染病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182352149627a658&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182352149627a658&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4583","BK4139","INO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511694847","title":"伊诺维奥制药盘中异动 早盘急速拉升5.16%报2.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511694847","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511694847?lang=zh_cn&edition=full","pubTime":"2025-02-14 23:13","pubTimestamp":1739546035,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日23时13分，伊诺维奥制药股票出现波动，股价快速拉升5.16%。截至发稿，该股报2.24美元/股，成交量22.4472万股，换手率0.62%，振幅5.63%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。伊诺维奥制药股票所在的生物技术行业中，整体涨幅为0.05%。伊诺维奥制药公司简介：Inovio Pharmaceuticals Inc是一家总部位于美国的生物技术公司，致力于开发基于DNA的活性免疫疗法和疫苗，以治疗和预防癌症和传染病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214231355abcf104d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214231355abcf104d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","BK4583","INO"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.inovio.com","stockEarnings":[{"period":"1week","weight":-0.088},{"period":"1month","weight":0},{"period":"3month","weight":-0.3214},{"period":"6month","weight":-0.4493},{"period":"1year","weight":-0.4623},{"period":"ytd","weight":-0.3448}],"compareEarnings":[{"period":"1week","weight":0.005},{"period":"1month","weight":0.0505},{"period":"3month","weight":0.107},{"period":"6month","weight":0.1},{"period":"1year","weight":0.2653},{"period":"ytd","weight":0.1061}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Inovio Pharmaceuticals, Inc.最初成立于1983年6月29日，按照加利福尼亚州法律以生物科技实验公司之名注册。该公司是一家临床阶段的生物技术公司，专注于开发和商业化DNA药物，以帮助治疗和保护人们免受与人乳头瘤病毒（HPV）、癌症和传染病相关的疾病的影响。该公司平台利用体内蛋白质生产的力量，以优化设计和交付DNA药物为特色，教会身体制造抗病工具。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.073076},{"month":2,"riseRate":0.25,"avgChangeRate":-0.037674},{"month":3,"riseRate":0.583333,"avgChangeRate":0.110594},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.016204},{"month":5,"riseRate":0.666667,"avgChangeRate":-0.007421},{"month":6,"riseRate":0.416667,"avgChangeRate":0.024161},{"month":7,"riseRate":0.454545,"avgChangeRate":-0.035078},{"month":8,"riseRate":0.545455,"avgChangeRate":0.010195},{"month":9,"riseRate":0.272727,"avgChangeRate":-0.085138},{"month":10,"riseRate":0.363636,"avgChangeRate":-0.037507},{"month":11,"riseRate":0.583333,"avgChangeRate":0.012377},{"month":12,"riseRate":0.166667,"avgChangeRate":-0.122282}],"exchange":"NASDAQ","name":"伊诺维奥制药","nameEN":"Inovio Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"伊诺维奥制药(INO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供伊诺维奥制药(INO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"伊诺维奥制药,INO,伊诺维奥制药股票,伊诺维奥制药股票老虎,伊诺维奥制药股票老虎国际,伊诺维奥制药行情,伊诺维奥制药股票行情,伊诺维奥制药股价,伊诺维奥制药股市,伊诺维奥制药股票价格,伊诺维奥制药股票交易,伊诺维奥制药股票购买,伊诺维奥制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"伊诺维奥制药(INO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供伊诺维奥制药(INO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}